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Epitope prediction is a critical step to diagnostic and vaccine discovery. Despite existence of some 
parameters for epitope discovery, this area remains inconclusive and wanting-for new complementary 
or stand-alone tools. The phenomenon of multiple protein-domain conservation architecture (MPDCA) 
as used here refers to homologous motifs unveiled by multiple sequence alignments across strain-
variants of the same protein aside of the conserved domains (CD) present within the same super family. 
Unpublished data suggests that MPDCA might be a confounder of epitope necessitating further 
investigation as a predictor of the same. The ease of determining MPDCA is appealing when considering 
protein-analysis; specifically epitope discovery. This study aimed to validate MPDCA as a predictive 
confounder of epitope. Using two-sets of surface viral glycoproteins of human immunodeficiency virus 
type I, HIV-1 (gp120) and Ebola virus, EBOV (gp1,2 preprotein) (selected because their CD-architecture 
has widely been studied, their sequences are available in public databases, and the same are well 
annotated), the MPDCAs among three different virus-strains in each-set, were compared to epitopes 
predicted by established tools (Bipred and DiscoTope). 4/6 (66.6%) of the linear epitopes confounded 
MPDCA, with 3/6 (50%) of these MPDCA’s confounding with the predicted linear epitopes (LE) at 
identities of > 50%, when compared to just 3/6 (50%) of the discontinuous epitopes (DE) that 
confounded with MPDCA at a < 50% identity. MPDCA is a non-deterministic confounder of Linear B cell 
epitopy. There is no causal relationship between the two, much as there is an evident co-occurrence. 
Therefore, MPDCA cannot accurately be used as an additional parameter to predict linear and or non-
linear B cell epitopes. 
 





Protein-epitopes or antigenic determinants are surface 
situated protein-motifs that are recognized by either the B 
or T cell arm of the immune system. Protein-epitopes can 
either be conformational (non-linear, discontinuous) or 
linear(Huang and Honda, 2006). Identifying epitopes of 
particular pathogen-proteins, represents a critical step in 
the discovery of diagnostics and vaccines for infectious 
diseases. As a consquence, several groups have 
previously focused on uncovering the biophysical 
determinants of epitope (Korber et al., 2006). Despite the
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rigorous inquest to which the subject of epitope prediction 
has been subjected, the accurate prediction of epitope 
remains incomplete (Korber et al., 2006; Emini et al., 
1985; Chou and Fasman, 1978; Haste Andersen et al., 
2006; Karplus and Schulz, 1985; Kolaskar and 
Tongaonkar, 1990; Larsen et al., 2006; Parker et al. 
1986; Zhang et al., 2008). New parameters are sought to 
complement or even replace the existing ones as a 
strategy to enhance the process of epitope prediction. 
Proteins belonging to a particular super family are 
defined by the presence of conserved domains (CD) 
therein. CD have previously been grouped together into a 
conserved domain database (CDD) as a strategy to allow 
easy annotation of newly sequenced proteins (Sievers et 
al., 2011; Geer et al., 2002; Marchler-Bauer et al., 2011). 
On the contrary, multiple sequence alignments of variants 
of the same protein from say different pathogen-strains 
within the same species (which are thereby homologous) 
reveals the occurence of 100% identical  sequence-
conservation which is not necessarily of CD nature 
(Sievers et al., 2011). Henceforth, we chose to refer to 
this phenomenon as „multiple protein-domain conser-
vation architecture (MPDCA)‟. We have co-incidentally 
previously uncovered a repetitive occurence of B cell 
epitope within the context of MPDCA (Unpublished data), 
findings which have prompted us to question if MPDCA 
may be a confounder useful towards epitope prediction. 
Such quest is justified by the fact that MPDCA is an easy 
and fast parameter to investigate which if proven to be 
predictive of epitopy, will simplify vaccine or diagnostic 
discovery.   
This study aimed to validate MPDCA as a predictive 
confounder of epitopy. To do so, we used two-sets of 
surface viral glycoproteins of human immunodeficiency 
virus type I, HIV-1 (gp120) and Ebola virus, EBOV (gp1,2 
preprotein) (selected because their CD-architecture has 
widely been studied, their sequences are available in 
public databases, and the same are well annotated). The 
MPDCAs in these two-sets of viral glycoproteins among 
three different virus-strains in each-set, were compared 
to epitopes predicted by established tools (Bipred and 
DiscoTope). The authors report results to confirm a non-
deterministic confounding of MPDCA with linear B cell 
epitope (LC); but no definitive correlation with 
discontinuous epitope (DE).  
 
 
MATERIALS AND METHODS 
 
This study was limited to in-silico sequence analyses, which did not 
necessitate the author to seek ethical approval from his institutional 
review board(s). All analyses presented below where done using 
default settings of software and databases described.  
 
 
Identifying MPDCAs of the case-study HIV-1 and EBOV strain 
glycoproteins  
 
Affirming super-family evolutionary ancestory across the case-
study viral glycoproteins  
 





Software, databases and sequences: Conserved domain 
architecture retrieval tool (cDART) (Geer et al., 2002), reverse 
position-specific (RPS)- basic local sequence alignment tool 
(BLAST) (Altschul et al. 1997), the conserved domain database 
(Marchler-Bauer et al., 2011), accession # of the case-study viral 
glycoproteins of HIV [HIV-1 Clade B (France) SP “|Q00A19|” 
corresponding to HIVSeqDB “|DQ863898|” (Labrosse et al., 2006); 
HIV-1 Clade D (Uganda) SP “|D0EMT9|” corresponding to 
HIVSeqDB “Z19524” (Bruce et al.,  1993); HIV-1 Clade B (USA) SP 
“|D0EMT9|” corresponding to HIVSeqDB “|GQ859302|” (Liu et al., 
2009); and EBOV [EBOV Zaire (Mayinga) SP “|Q05320|” (Sanchez 
et al., 1993); EBOV Sudan (Uganda-00) SP“|Q7T9D9|” (Sanchez et 
al., 2004);  EBOV Reston (Reston-89) SP “|Q66799|” (Sanchez et 
al., 1996). 
The details of amino acid sequences are listed in supporting file 
S1. 
 
Intervention: We searched the CDD for conserved domains (CD) 
by feeding the accession # of the respective case-study viral 
glycoproteins into the RPS-BLAST linked to the CDD as per user 
guide. 
 
Measured variables: CD specific to the viral glycoprotein super-
family.   
 
 
Unveiling MPDCAs among the case-study viral glycoproteins  
 
Design: In-silico multiple sequence analysis 
 
Software, databases and sequences: Clustal Omega (Sievers et 
al., 2011), and FASTA format amino acids (Aa) sequences of the 
case-study viral glycoproteins of HIV-1 and EBOV were used are 
details are shown in supporting file S1 (Table 1). 
  
Intervention: Multiple sequence alignments of the above HIV-1 and 
EBOV glycoprotein was done by individually feeding the FASTA 
formats of the individual virus-group‟s (either HIV-1 or EBOV)  
glycoproteins‟ amino acid sequences into the Clustal omega 
software at default setting. 
 
Measured variables: MPDCA were defined as peptides of > 6 Aa 
length and cross-strain homology of 100%. Peptides of > 6 Aa were 
selected, as this is the recognized minimum peptide length with 
variable reconstructable immunogenicity in-vivo (Emini et al., 1985; 
Chou and Fasman, 1978; Haste Andersen et al., 2006; Karplus and 
Schulz, 1985; Kolaskar and Tongaonkar, 1990; Larsen et al., 2006; 
Parker et al. 1986; Zhang et al., 2008). 
 
 
Exposing B cell epitopes within the case-study viral 
glycoproteins 
 




Software, databases and sequences: Bepipred linear B cell 
prediction software (Larsen et al., 2006) and FASTA format amino 
acids (Aa) sequences of the case-study viral glycoproteins of HIV-1 
and EBOV are detailed in supporting file S1 (Table 1). 
   
Intervention: Linear B cell epitopes were derived by feeding the 
FASTA formats of the amino acids (Aa) sequences of the case-
study viral glycoproteins of HIV-1 and EBOV into the Bepipred user 
interface at default. 
  
Measured variables: Linear B cell epitopes.   












This file offers details of HIV Sequence Database/Swiss-prot accession numbers, FASTA formats and 
Amino acid loci of all HIV-1 and EBOV glycoproteins used in this study 
S2 MS.xcel 
This file details superfamily conserved domains of the HIV-1 clade B (France) glycoprotein used in this 
study 
S3 MS.xcel 
This file details superfamily conserved domains of the HIV-1 clade D (Uganda) glycoprotein used in this 
study 
S4 MS.xcel This file details superfamily conserved domains of the HIV-1 clade B (USA) glycoprotein used in this study 
S5 MS.xcel 
This file details superfamily conserved domains of the EBOV Zaire (Mayinga) glycoprotein used in this 
study 
S6 MS.xcel 
This file details superfamily conserved domains of the EBOV Sudan (Uganda-00) glycoprotein used in this 
study 
S7 MS.xcel 
This file details superfamily conserved domains of the EBOV Reston (Reston-89) glycoprotein used in this 
study 
S8 Pdf 
This file shows RST-BLAST results obtained by searching one of the HIV-1 clade (B, France) 
glycoproteins across the conserved domain database, CDD 
S9 Pdf 
This file shows RST-BLAST results obtained by searching one of the EBOV (Zaire, Mayinga) 
glycoproteins across the conserved domain database, CDD 
S10 MS.doc 
This file details multiple protein domain conservation architecture revealed by multiple sequence 
alignment of all three HIV-1 strains‟ glycoproteins 
S11 MS.doc 
This file details multiple protein domain conservation architecture revealed by multiple sequence 
alignment of all three EBOV strains‟ glycoproteins 
S12 MS.doc 
This file shows correlation of MPDCA with linear epitopes predicted by Bepipred across sequences of HIV-
1 Clade B (France)‟s glycoprotein 
S13 MS.doc 
This file shows correlation of MPDCA with linear epitopes predicted by Bepipred across sequences of HIV-
1 Clade D (Uganda)‟s glycoprotein 
S14 MS.doc 
This file shows correlation of MPDCA with linear epitopes predicted by Bepipred across sequences of HIV-
1 Clade B (USA)‟s glycoprotein 
S15 MS.doc 
This file shows correlation of MPDCA with linear epitopes predicted by Bepipred across sequences of 
EBOV Zaire (Mayinga)‟s glycoprotein 
S16 MS.doc 
This file shows correlation of MPDCA with linear epitopes predicted by Bepipred across sequences of 
EBOV Sudan (Uganda-00)‟s glycoprotein 
S17 MS.doc 
This file shows correlation of MPDCA with linear epitopes predicted by Bepipred across sequences of 
EBOV Reston (Reston-89)‟s glycoprotein 
S18 MS.doc 
This file shows correlation of MPDCA with non-linear (discontinuous) epitopes predicted by Bepipred 
across sequences of HIV-1 Clade B (France)‟s glycoprotein 
S19 MS.doc 
This file shows correlation of MPDCA with non-linear (discontinuous) epitopes predicted by Bepipred 








Software, databases and sequences: DiscoTope conformational 
B cell prediction software (Haste Andersen et al., 2006) and 3-D 
crystal structure accession # for the case-study viral glycoproteins 
of HIV-1 and EBOV (PDB entry “3dnl” and “3CSY” respectively). 
 
Intervention: Conformational B cell epitopes were derived by 
individually feeding the PDB entry accessions of the case-study 
viral glycoproteins of HIV-1 and EBOV into the DiscoTope user 
interface at default.  
Measured variables: Conformational B cell epitopes.   
 
 
Correlating multiple domain conservation architectures with 
predicted epitope among the case-study vira; glycoproteins 
 
This was more of a mathematical or statistical analysis of the data 
above; with a focus on ascertaining the correlation between 
epitopes and MPDCA. The few cases used for this validation stage 
could not permit derivation of variation coefficients with statistical 
significance. Instead, a cross-tabulation of MPDCA with either linear 
epitope (LE) or discontinuous epitope (DE) was done.  






Figure 1. Evolutionary relationship between the strain-specific variants of the HIV-1 glycoprotein gp120 as revealed by conserved domain 
architecture. Description: phylogenetic tree revealing the evolutionary relationship between the strain-specific variants of the HIV-1 




Availability of supporting data 
 
"The data set(s) supporting the results of this article is (are) 
included within the article (and its additional file(s)" (Table 1). 
 
 
RESULTS AND DISCUSSION 
 
The results confirm a non-deterministic confounding of 
MPDCA with linear B cell epitope (LC); and no definitive 
correlation with discontinuous epitope (DE).  
 
 
MPDCA among EBOV and HIV-1 strain glycoproteins  
 
First, the presence of conserved-domains consistent with 
the viral glycoprotein super-families studied was affirmed 
and subsequently unveiled multiple protein domain 




Super-family conserved domains (CD) across the 
case-study viral glycoproteins 
 
All case-study viral glycoproteins were affirmed to lie 
within the HIV-1 and EBOV super-family of glycoproteins 
(for details, see additional files S1, S2, S3, S4, S5, S6, 
and S7) (Table 1). A phylogenetic illustration of this 
evolutionary ancestry across the HIV-1 case study 
glycoproteins, gp120 is shown in Figure 1. Schematics of 
the conserved domain architecture within the case-study 
viral glycoproteins are shown in the RST-BLAST results 
detailed in additional supporting files S8 and S9 (Table 
1). 
These data served to justify our choice of strain-type 
variants of the study viral glycoproteins within the same 
species of virus. CD may be viewed as functional protein 
motifs, which by virtue of their inter-network molecules 
within a network assume evolutionary patterns of hub-
proteins. Therefore as pathogens evolve (presumably 
across strains in the same species), the CD are 
maintained to sustain their functionality. Further, because 
CDs are functional motifs which must interact with ligands 
in the network, the same are often located on the surface, 
thereby explaining the confounding between CD and 
epitope (Geer et al., 2002; Marchler-Bauer et al., 2011). 
The multiple protein-domain conservation architecture 
(MPDCA) revealed that, on the other hand, may or may 
not be functional motifs as is elucidated by prior studies 
and further evidence provided. Nonetheless, it appears 
that the same MPDCA are under pressure from other 




MPDCA among the case-study viral glycoproteins 
 
Six (6) MPDAs with more than six amino acids (Aa) 
length and 100% identity were unveiled in each of the 
case-study glycoprotein groups, HIV-1 gp120 and EBOV 
gp1,2. The respective details of these findings are shown 
by different color shades in supporting files S10 and S11 
(Table 1). Fraser et al. (2002) previously found that the 
connectivity of well-conserved proteins in the network is 
negatively correlated with their rate of evolution. Overall, 
this group showed that proteins with more interactions 
evolve more slowly not because they are more important 
to the organism, but because a greater proportion of the 
protein is directly involved in its function. In contrast to 
this claim that proteins with more interaction partners 
(sometimes called hubs) are- owing to an assumed high 
density of binding sites, both physiologically more 
important and slow evolving; Batada et al. (2006) found 
that hub proteins are indeed more important for cellular 
growth rate and are under tight regulation but are not 
slow evolving. These studies suggest that at sites 
important for interaction between proteins (such as the 
MPDCA which were studied), evolutionary changes occur 
largely by coevolution, in which substitutions in one 
protein result in selection pressure for reciprocal changes 
in interacting partners. He argued that, in the same 
manner as evolutionary changes in the B cell paratrope 
could potentially influence epitope architecture, MPDCA 
may be under pressure from their indeterminate 
interactions. Such analogy to hub proteins with regards to 
the conservation patterns of protein domains is, however, 
debatable. Specifically, the primary reason for 
conservation of sequence across a domain is 
preservation of the domain fold and secondary structure 
elements (internal interactions). Conservation of active 
site residues and structure, and conservation of binding 
regions contribute to local sequence conservation (that is, 
within the same functional sub-family). Also, the 
assumption of a co-evolutionary model may not be 
universal, since this will only occur when the domain




Table 2. Correlation of MPDCA with linear and discontinuous epitope among the case-study HIV-1 glycoproteins. 
 
(Position)_Multiple protein-domain conservation 
architecture (MPDCA) 
Length (Aa) 
Occupied by linear 
epitope (LE/MPDCA) 
Occupied by discontinuous 
epitopy 
(DE/MPDCA) 
74_DIISLWDQSLKPCVKLTPLCVTLNCT 27 0/27 0/27 
177_ITQACPKVTFEPIPI 15 7/15 2/15 
192_HYCAPAGFAILKC 13 0/13 0/13 
229_PVVSTQLLLNGSLAE 15 1/15 0/15 
401_VGKAMYAPPI 10 8/10 1/10 
442_FRPGGGDMRDNWRSELYKYK 21 12/21 6/21 
 




Table 3. Correlation of MPDCA with linear and discontinuous epitope among the case-study EBOV glycoproteins. 
 
(Position)_Multiple protein-domain 
conservation architecture (MPDCA) 
Length 
(Aa) 
Occupancy by linear 
epitope (LE/MPDCA) 
Occupancy by discontinuous epitopy 
(DE/MPDCA) 
99_YEAGEWAENCYNLEIKK 17 10/17 0/17 
130_RGFPRCRYVHK 11 1/11 0/11 
157_GAFFLYDRLASTVIYRG 17 0/17 0/17 
559_RQLANETTQALQLFLRATTELR 22 3/22 0/22 
586_LNRKAIDFLLQRWGGTC 17 0/17 0/17 




interacts with another protein (or DNA/RNA segment). 
However, most domain function (enzymes, signalling) 
involve interactions with small molecules which do not 
"evolve". Also, protein domains occur in proteins 
throughout the cell, and are not predominantly associated 
with cell walls or membranes (Huang and Honda, 2006; 
Korber et al., 2006; Emini et al., 1985; Chou and 
Fasman, 1978; Haste Andersen et al., 2006; Karplus and 
Schulz, 1985; Kolaskar and Tongaonkar, 1990; Larsen et 
al., 2006; Parker et al. 1986; Zhang et al., 2008; Sievers 
et al., 2011; Geer et al., 2002; Marchler-Bauer et al., 
2011; Fraser  et al., 2002; Batada et al., 2006; Altschul et 
al., 1997; Labrosse et al., 2006; Bruce et al., 1993; Liu et 
al., 2009; Sanchez et al., 1993; Sanchez et al., 2004; 
Sanchez et al., 1996). 
 
 
B cell epitopes within the case-study viral 
glycoproteins 
 
We uncovered both linear and non-linear B cell epitopes 




Linear B cell epitopes prediction by bepipred 
 
Several  linear B cell epitopes  were  unveiled in all  case- 
study viral glycoproteins that are shown further in 




Non-linear B cell epitopes prediction by discotope 
 
The conformational B cell epitopes unveiled across the 
case- study viral glycoproteins are shown further in 
supporting files S18 and S19 (Table 1), respectively for 
HIV-1 and EBOV.  
 
 
Correlation of MPDCA and predicted epitope among 
the case-study viral glycoproteins 
 
The author observed an arbitrarily non-deterministic 
confounding of MPDCA with linear B cell epitope (LC); 
but no definitive correlation with discontinuous epitope 
(DE). Specifically, 4/6 (66.6%) of the linear epitopes 
confounded MPDCA, with 3/6 (50%) of these MPDCA‟s 
confounding with the predicted linear epitopes (LE) at 
identities of > 50% (Tables 1 and 2) when compared to 
just 3/6 (50%) of the discontinuous epitopes (DE) that 
confounded with MPDCA at a < 50% identity (Tables 2 
and 3). There are several weaknesses in our approach 
and findings. Since this was only a first-step in proof of 
concept,  and the small sample size used (there are  over  




100,000 sequences for HIV GP120) could not allow for 
derivation of variation coefficients, he argued that further 
expanded work is sought in this direction to better inform 
the performance of MPDCA. Further, the methods to 
which he compare the performance of MPDCA as a 
predictor of B cell epitope, have variable precision and 
are not necessary the best (Emini et al., 1985; Chou and 
Fasman, 1978; Haste Andersen et al., 2006; Karplus and 
Schulz, 1985; Kolaskar and Tongaonkar, 1990; Larsen et 
al., 2006; Parker et al. 1986; Zhang et al., 2008). 
Certainly in the case of the linear predictor the false 
positive prediction rate is very high making it unusable as 
a benchmark (no false negative rate given, because not 
much could be determined as this stage). 
Overall, these data show that MPDCA is a non-
deterministic confounder of linear B cell epitope. 
Moreover, there appears to be no causal relationship 
between the two, much as there is an evident co-
occurrence. Therefore, MPDCA cannot accurately be 
used as an additional parameter to predict linear and or 
non-linear B cell epitopes. The only possible applicability 
of MPDCA in epitope discovery is that of rapidly scanning 
across proteins to see areas that may be potentially 
epitopic.  More important to note outside of our findings is 
that MPDCA cannot predict antigenicity or 
immunogenicity. Further, another major shortcoming with 
using MPDCA to predict linear epitopy, is that MPDCA 
have the potential to interact with other players in the 
network, a behavior that might mask or even conceal 
their architecture in-vivo, making them inappropriate 
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